DHX34 and cutaneous melanoma: Furthermore, high DHX34 expression was associated with shorter PFI in ACC (HR = 4.42, 95% CI: 2.21-8.86, p < 0.001), KIRP (HR = 2.00, 95% CI: 1.16-3.44, p = 0.012), LGG (HR = 1.97, 95% CI: 1.49-2.62, p < 0.001), LIHC (HR = 1.53, 95% CI: 1.14-2.04, p = 0.004), and Skin Cutaneous Melanoma (SKCM) (HR = 1.29, 95% CI: 1.03-1.61, p = 0.028) (Fig. 5P-T).